What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction

(2019) Pieter Martens et al.   Clinical Research in Cardiology

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials

(2018) Xavier Rossello et al.   Clinical Research in Cardiology

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

(2018) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Declining Risk of Sudden Death in Heart Failure

(2017) Li Shen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy

(2016) Evan C Adelstein et al.   EUROPACE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cascading network failure across the Alzheimer’s disease spectrum

(2015) David T. Jones et al.   BRAIN

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

(2015) Akshay S. Desai et al.   EUROPEAN HEART JOURNAL

Interaction Between Digoxin and Dronedarone in the PALLAS Trial

(2014) Stefan H. Hohnloser et al.   Circulation-Arrhythmia and Electrophysiology

Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities

(2014) Benjamin A. Steinberg et al.   JACC-Heart Failure

The STICH Trial (Surgical Treatment for Ischemic Heart Failure)

(2013) Peter Carson et al.   JACC-Heart Failure

Analysis of Cascading Failure in Gene Networks

(2012) Longxiao Sun et al.   Frontiers in Genetics

Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction

(2011) Richard M. Cubbon et al.   Circulation-Heart Failure

Reverse Remodeling and the Risk of Ventricular Tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy)

(2011) Alon Barsheshet et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death

(2011) Leah Iles et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevalence and Prognostic Significance of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Receiving Tailored Medical Treatment

(2011) Marco Merlo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial

(2010) Henry Krum et al.   Cardiovascular Therapeutics

Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome

(2010) Scott D. Solomon et al.   CIRCULATION

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

(2009) Douglas L. Packer et al.   CIRCULATION

Predictors of Mortality From Pump Failure and Sudden Cardiac Death in Patients With Systolic Heart Failure and Left Ventricular Dyssynchrony: Results of the CARE-HF Trial

(2008) Barry F. Uretsky et al.   JOURNAL OF CARDIAC FAILURE

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET